Renal transplantation in HIV-infected patients: 2010 update (Q37830308)

24 August 2017

1 reference

title

Renal transplantation in HIV-infected patients: 2010 update (English)

1 reference

24 August 2017

Mercedes Brunet

5

0 references

Carlos Cervera

object named as

Carlos Cervera

6

0 references

author name string

Joan C Trullas

1

1 reference

24 August 2017

Federico Cofan

2

1 reference

24 August 2017

Montse Tuset

3

1 reference

24 August 2017

María J Ricart

4

1 reference

24 August 2017

Christian Manzardo

7

1 reference

24 August 2017

María López-Dieguez

8

1 reference

24 August 2017

Federico Oppenheimer

9

1 reference

24 August 2017

Asuncion Moreno

10

1 reference

24 August 2017

Josep M Campistol

11

1 reference

24 August 2017

Jose M Miro

12

1 reference

24 August 2017

language of work or name

English

0 references

publication date

19 January 2011

1 reference

24 August 2017

1 reference

24 August 2017

79

1 reference

24 August 2017

8

1 reference

24 August 2017

825-842

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2010.545

24 August 2017

0 references

cites work

Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Kidney transplants in HIV-positive recipients under HAART. A comprehensive review and meta-analysis of 12 series.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Antiretroviral therapy in the treatment of HIV-associated nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Dialysis and Renal Transplantation in HIV-Infected Patients: a European Survey

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

National surveillance of dialysis-associated diseases in the United States, 2002.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

The clinical characteristics of HIV-infected patients receiving dialysis in France between 1997 and 2002.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

[Prevalence of HIV-1-infection in dialysis units in Spain and potential candidates for renal transplantation: results of a Spanish survey]

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Prevalence and clinical characteristics of HIV type 1-infected patients receiving dialysis in Spain: results of a Spanish survey in 2006: GESIDA 48/05 study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

HIV infection in renal dialysis patients in Egypt

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Prevalence of ATLV and HIV among hemodialysis patients in Japan

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Outcome of patients with human immunodeficiency virus on maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Determinants of survival among HIV-infected chronic dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Outcome and Prognosis Factors in HIV-Infected Hemodialysis Patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Guidelines for kidney transplantation in patients with HIV disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Racial disparities in access to renal transplantation--clinically appropriate or due to underuse or overuse?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Factors associated with failure to list HIV-positive kidney transplant candidates.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

The effect of cyclosporine on the progression of human immunodeficiency virus type 1 infection transmitted by transplantation--data on four cases and review of the literature.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Renal transplantation in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Transmission of human immunodeficiency virus by transplantation of a renal allograft, with development of the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Acquired immunodeficiency syndrome transmitted by transplanted kidney: clinical course during maintenance haemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

HIV infection in cadaveric renal allograft recipients in the North Italy Transplant Program

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Transmission of AIDS virus at renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

HTLV-III infection in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

HIV infection in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Long-term survival in an HIV-infected renal transplant recipient

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Transmission of Human Immunodeficiency Virus Type 1 from a Seronegative Organ and Tissue Donor

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Transmission of human immunodeficiency virus (HIV) by transplantation: clinical aspects and time course analysis of viral antigenemia and antibody production

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Acute human immunodeficiency virus infection. Antigen detection and seroconversion in immunosuppressed patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Determination of acquired immunodeficiency syndrome (AIDS) after renal transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Transplantation in HIV+ patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Impact of HIV seropositivity on graft and patient survival after cadaveric renal transplantation in the United States in the pre highly active antiretroviral therapy (HAART) era: an historical cohort analysis of the United States Renal Data System.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Human immunodeficiency virus infection and kidney transplantation in the era of highly active antiretroviral therapy and modern immunosuppression

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

HIV-positive renal recipients can achieve survival rates similar to those of HIV-negative patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Transplantation in the HIV+ patient

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Solid organ transplantation in HIV-positive patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Review of solid-organ transplantation in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Kidney-pancreas transplantation in a long-term non-progressor HIV-infected recipient

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Preliminary experience with renal transplantation in HIV+ recipients: low acute rejection and infection rates

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Combined liver-kidney transplantation in an HIV-HCV-coinfected patient with haemophilia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Effect of thymoglobulin induction on HIV-infected renal transplant recipients: differences between HIV-positive and HIV-negative patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Kidney transplantation in HIV-positive patients: report of our first 7 cases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Renal transplantation in HIV-infected patients: the Paris experience.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Outcomes of kidney transplantation in HIV-infected recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Combined CXCR3/CCR5 blockade attenuates acute and chronic rejection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

CC chemokine receptor 5 and renal-transplant survival

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Indinavir pharmacokinetics in haemodialysis-dependent end-stage renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Antiviral therapy for HIV patients with renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Lack of removal of nelfinavir during a haemodialysis session in an HIV-1 infected patient with hepatic and renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Pharmacokinetics and dosing recommendations of tenofovir disoproxil fumarate in hepatic or renal impairment

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Steady-state disposition of the nonpeptidic protease inhibitor tipranavir when coadministered with ritonavir

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Efavirenz dosing in patients receiving continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Pharmacokinetics of tenofovir in haemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Tipranavir: a novel nonpeptidic protease inhibitor of HIV.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Enfuvirtide does not require dose adjustment in patients with chronic kidney failure: results of a pharmacokinetic study of enfuvirtide in HIV-1-infected patients with impaired kidney function

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Renal transplantation between HIV-positive donors and recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Are HIV-infected donors suitable for renal transplantation?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Effects of immunosuppressive drugs on HIV infection: implications for solid-organ transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Cyclophilin a modulates processing of human immunodeficiency virus type 1 p55Gag: mechanism for antiviral effects of cyclosporin A.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovir

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Effect of mycophenolate mofetil on the pharmacokinetics of antiretroviral drugs and on intracellular nucleoside triphosphate pools

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Rapamycin reduces CCR5 mRNA levels in macaques: potential applications in HIV-1 prevention and treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Sirolimus for Kaposi's sarcoma in renal-transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Continuing or adding IL-2 in patients treated with antiretroviral therapy (ACTG Protocol A5051, a rollover trial of ACTG Protocol A328)

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Thymoglobulin-associated Cd4+ T-cell depletion and infection risk in HIV-infected renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Single dose of Rituximab plus plasmapheresis in an HIV patient with acute humoral kidney transplant rejection: a case report

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Pharmacokinetic interaction between saquinavir and cyclosporine

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Probable interaction between efavirenz and cyclosporine

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Safe use of raltegravir and sirolimus in an HIV-infected patient with renal impairment after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Pharmacokinetic interaction between Amprenavir/Ritonavir and FosAmprenavir on cyclosporine in two patients with human immunodeficiency virus infection undergoing orthotopic liver transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

The addition of mycophenolate mofetil to antiretroviral therapy including abacavir is associated with depletion of intracellular deoxyguanosine triphosphate and a decrease in plasma HIV-1 RNA.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Tacrolimus and lopinavir/ritonavir interaction in liver transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Concomitant human immunodeficiency virus protease inhibitor therapy markedly reduces tacrolimus metabolism and increases blood levels.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

The impact of transplantation with deceased donor hepatitis c-positive kidneys on survival in wait-listed long-term dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

The impact of hepatitis C virus viremia on renal graft and patient survival: a 9-year prospective study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Pegylated interferon for the treatment of hepatitis C virus in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Histopathologic efficacy of ribavirin monotherapy in kidney allograft recipients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Lack of evidence for ribavirin monotherapy efficacy on liver fibrosis in hepatitis C virus positive renal transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Risk factors for cardiovascular events after successful renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Renal disease in patients with HIV infection: epidemiology, pathogenesis and management

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Key clinical, ethical, and policy issues in the evaluation of the safety and effectiveness of solid organ transplantation in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Simultaneous pancreas-kidney transplantation in HIV-infected patients: a case report and literature review

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Simultaneous pancreas-kidney transplantation in a human immunodeficiency virus-positive recipient: a case report

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.545

7 January 2021

Identifiers

DOI

10.1038/KI.2010.545

1 reference

24 August 2017

1 reference